Westlake Corporation
WLK
$80.28
-3.83%
Westlake Corporation is a vertically integrated international manufacturer and marketer of performance and essential materials, as well as housing and infrastructure products, operating within the specialty chemicals industry. The company is a significant player with a distinct identity as a vertically integrated producer, controlling its supply chain from basic chemical feedstocks to finished building products. The current investor narrative is dominated by the severe cyclical downturn in the chemical sector, as evidenced by recent quarterly losses and negative margins, with recent news highlighting how geopolitical tensions are exacerbating supply shocks and margin pressures across global commodities, including chemicals.…
WLK
Westlake Corporation
$80.28
Investment Opinion: Should I buy WLK Today?
Rating: Hold. The core thesis is that WLK is a deeply cyclical stock in the midst of a severe downturn, where catastrophic near-term fundamentals (-17.25% gross margin) are balanced against a historically cheap sales multiple (0.85x PS) and analyst hopes for a sharp 2026 recovery. The lack of a clear analyst consensus underscores the high uncertainty.
Supporting evidence for a Hold includes the valuation at 0.85x trailing sales and 1.44x EV/Sales, which is low historically but justified by current losses. Revenue is declining at -10.9% YoY, and profitability has collapsed. However, analyst forward EPS of $4.17 implies a forward P/E of 22x, suggesting the market is already pricing in a significant recovery. The balance sheet shows adequate liquidity with a 2.24 current ratio, providing a margin of safety.
The thesis would upgrade to a Buy on evidence of margin stabilization, such as a return to positive gross margin in the next quarterly report, or if the stock price approaches the $56.33 technical support level, offering a larger margin of safety. It would downgrade to a Sell if quarterly cash burn accelerates beyond -$530M TTM or if revenue decline accelerates further. Relative to its own history, the stock is undervalued on a sales basis, but fairly valued given the current depth of its losses. It is a speculative bet on a cyclical turnaround, not a value investment with visible near-term catalysts.
Sign up to view all
WLK 12-Month Price Forecast
WLK is a classic 'falling knife' in a deep cyclical downturn. The near-term fundamentals are undeniably terrible, but the stock's valuation reflects a pessimistic scenario. The investment decision hinges entirely on the timing and strength of a cyclical recovery for which there is no current evidence. The neutral stance reflects this high uncertainty; the stock could rally sharply on any positive margin news but could also fall further if losses continue. The stance would upgrade to bullish on concrete evidence of margin stabilization (e.g., a return to positive gross margin) or a further drop towards the $56 support level. It would turn bearish if the next quarter shows accelerating revenue decline or cash burn.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Westlake Corporation's 12-month outlook, with a consensus price target around $104.36 and implied upside of +30.0% versus the current price.
Average Target
$104.36
9 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
9
covering this stock
Price Range
$64 - $104
Analyst target range
Insufficient analyst coverage available to provide a detailed consensus view. The provided data includes estimates from 9 analysts for future EPS and revenue, but lacks critical consensus metrics such as an average price target, recommendation distribution (Buy/Hold/Sell), or a target price range. This limited coverage is typical for a mid-cap chemical company and can lead to higher volatility and less efficient price discovery, as institutional interest may be more muted compared to larger peers. The recent institutional rating actions show a mix of Buy, Neutral, and Equal Weight recommendations, with one upgrade from BMO Capital in early March, but without price targets, the implied market sentiment and upside potential cannot be quantified.
Bulls vs Bears: WLK Investment Factors
The bear case currently holds stronger evidence, anchored by the severe and worsening fundamental deterioration in Q4 2025, including a -17.25% gross margin and a -10.9% revenue decline. The bull case rests on deep-value valuation (0.85x PS) and analyst expectations for a sharp 2026 EPS recovery to $4.17. The single most important tension in the investment debate is the timing and magnitude of a cyclical recovery in chemical margins. If Westlake can stem losses and demonstrate a path back to positive cash flow in the next quarter, the deeply depressed valuation could provide substantial upside. However, if the downturn deepens or persists, the current cash burn could erode the balance sheet strength that underpins the bull thesis.
Bullish
- Valuation at Cyclical Trough: The stock trades at a PS ratio of 0.85x, near the lower end of its historical range and well below its recent high above 6x. This suggests the market has priced in a severe downturn, leaving room for significant multiple expansion if fundamentals stabilize.
- Strong Balance Sheet Liquidity: The current ratio of 2.24 indicates ample short-term liquidity to weather the cyclical downturn. This financial flexibility is critical for a capital-intensive chemical company facing negative free cash flow of -$530M TTM.
- Analyst Forward EPS Optimism: Analysts project a sharp recovery to an average forward EPS of $4.17, implying a forward P/E of 22.0x. This expectation, if met, would represent a dramatic turnaround from the current quarterly loss of -$4.22 per share.
- Technical Oversold Bounce Potential: The stock is down 23.82% in one month and trades near $88.10, close to the lower end of its 52-week range ($56.33-$124.23). This severe short-term decline, coupled with a beta of 0.67, suggests an oversold condition ripe for a technical rebound.
Bearish
- Severe Profitability Collapse: Q4 2025 gross margin was -17.25% and net income was -$544M, indicating a catastrophic breakdown in pricing power and cost structure. This is a sharp deterioration from even modestly positive margins in earlier 2025 quarters.
- Deepening Revenue Decline: Q4 2025 revenue of $2.53B declined 10.9% YoY, worsening sequentially from Q2 and Q3. This confirms a deepening cyclical slump in demand for its chemicals and building products, with no clear bottom in sight.
- Sustained Cash Burn: Trailing twelve-month free cash flow is -$530 million, indicating the company is burning cash despite its liquidity. This raises financial strain risks if the downturn persists longer than anticipated, potentially pressuring the balance sheet.
- Macro & Geopolitical Headwinds: Recent news highlights the Iran conflict exacerbating commodity supply shocks, directly pressuring chemical margins. The company's vertically integrated model may not shield it from these broad-based global price and margin pressures.
WLK Technical Analysis
The stock is in a pronounced downtrend, having declined 23.82% over the past month and 6.67% over the past three months, which starkly contrasts with its positive 19.60% gain over the past year. Currently trading at $88.10, the price sits near the lower end of its 52-week range of $56.33 to $124.23, indicating significant weakness and potential oversold conditions after a sharp reversal from recent highs. Recent momentum is decisively negative, with the 1-month decline of 23.82% far exceeding the S&P 500's 5.49% gain, resulting in severe relative underperformance, and this short-term collapse suggests a breakdown from the prior uptrend, likely driven by deteriorating fundamentals. Key technical support is at the 52-week low of $56.33, while immediate resistance lies at the recent breakdown level near $100; a beta of 0.67 indicates the stock has been less volatile than the market historically, but the recent plunge suggests idiosyncratic risk is currently dominant.
Beta
0.59
0.59x market volatility
Max Drawdown
-37.8%
Largest decline past year
52-Week Range
$56-$124
Price range past year
Annual Return
+12.8%
Cumulative gain past year
| Period | WLK Return | S&P 500 |
|---|---|---|
| 1m | -9.5% | +1.8% |
| 3m | -24.3% | +15.1% |
| 6m | +10.7% | +9.7% |
| 1y | +12.8% | +25.0% |
| ytd | +8.3% | +9.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
WLK Fundamental Analysis
Revenue is under significant pressure, with Q4 2025 revenue of $2.53 billion representing an 10.9% year-over-year decline, and the trend has worsened sequentially from Q2 and Q3 2025, indicating a deepening cyclical slump in demand. The company is deeply unprofitable, reporting a Q4 net loss of $544 million and a gross margin of -17.25%, reflecting severe margin compression as input costs likely outpaced selling prices, with profitability deteriorating sharply from the modestly positive gross margins seen in earlier 2025 quarters. The balance sheet shows a current ratio of 2.24 and a debt-to-equity ratio of 0.73, indicating adequate liquidity but elevated leverage, while trailing twelve-month free cash flow is deeply negative at -$530 million, signaling the company is burning cash and may face financial strain if the downturn persists.
Quarterly Revenue
$2.5B
2025-12
Revenue YoY Growth
-0.10%
YoY Comparison
Gross Margin
-0.17%
Latest Quarter
Free Cash Flow
$-530000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is WLK Overvalued?
Given the negative net income and EBITDA, the primary valuation metric is the Price-to-Sales (PS) ratio. The trailing PS ratio is 0.85, while the Enterprise Value-to-Sales (EV/Sales) is 1.44, providing a sales-based valuation anchor in the absence of profits. Compared to industry averages, data is not available for a direct sector comparison of PS or EV/Sales multiples, making it difficult to quantify a premium or discount; however, the sub-1x PS ratio suggests the market is assigning a low multiple to revenue due to the current loss-making profile. Historically, the stock's own PS ratio has fluctuated significantly, with a recent high above 6x in 2024; the current PS of 0.85 is near the lower end of its historical range, suggesting the market is pricing in pessimistic expectations for a prolonged downturn or fundamental deterioration.
PE
-6.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -80x~526x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-66.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and immediate. The company reported a Q4 net loss of -$544M with a gross margin of -17.25%, indicating a complete erosion of profitability. With TTM free cash flow at -$530M, the company is burning cash at an alarming rate. While the current ratio of 2.24 provides a liquidity buffer, the debt-to-equity ratio of 0.73 means elevated leverage could become problematic if losses continue, potentially limiting financial flexibility just when it's needed most.
Market & Competitive Risks are heightened by the cyclical nature of the specialty chemicals industry and current macro pressures. The stock's beta of 0.67 suggests it should be less volatile than the market, but its 23.82% one-month plunge against a +5.49% S&P 500 shows extreme idiosyncratic risk from its operational collapse. Geopolitical tensions, as noted in recent news, are creating supply shocks that further compress margins for commodity chemicals, directly impacting Westlake's core segments. The lack of a clear analyst consensus or price targets adds to valuation uncertainty and price discovery risk.
Worst-Case Scenario involves a prolonged chemical sector downturn exacerbated by persistent geopolitical supply shocks, leading to continued quarterly losses and accelerating cash burn. This could force the company to draw down liquidity, take on more expensive debt, or even cut its dividend (current yield 2.85%) to preserve capital. The realistic downside could see the stock re-test its 52-week low of $56.33, representing a potential loss of approximately -36% from the current price of $88.10. A drawdown of this magnitude is plausible given the stock's historical max drawdown of -40.5%.
FAQ
The key risks are, in order of severity: 1) Financial Risk: Continued cash burn (-$530M TTM) could erode the company's liquidity buffer and lead to financial strain or a dividend cut. 2) Operational Risk: The catastrophic gross margin of -17.25% indicates a severe breakdown in its business model amid a chemical sector downturn, with no clear bottom. 3) Macro/Cyclical Risk: The company is highly sensitive to global commodity prices and housing demand; geopolitical conflicts and a potential recession could prolong the downturn. 4) Sentiment/Valuation Risk: With limited analyst coverage and no clear price targets, the stock is prone to sharp swings on news, as evidenced by its 23.82% one-month plunge.
The 12-month forecast is highly uncertain, centered around three scenarios. The Base Case (50% probability) sees the stock trading between $85 and $100 as the downturn stabilizes without a sharp recovery. The Bull Case (25% probability) projects a rally to $115-$124 on a faster-than-expected cyclical rebound and margin recovery. The Bear Case (25% probability) warns of a decline to $56-$75 if losses deepen and cash burn accelerates. The Base Case is most likely, implying a roughly flat to slightly positive return from the current $88.10, but with high volatility. The key assumption is that the chemical cycle finds a bottom in 2026, but a robust recovery may not materialize until 2027.
WLK is fairly valued relative to its current disastrous fundamentals but historically undervalued on a sales basis. The trailing PS ratio of 0.85x is near the low end of its own historical range, which has been above 6x, suggesting the market is pricing in a prolonged downturn. With no profits, traditional P/E is negative. The forward P/E of 22x, based on analyst hopes for $4.17 EPS, indicates the market is already expecting a significant recovery. Therefore, the stock is not cheap on a forward earnings basis unless that recovery is exceeded. The valuation implies the market expects a cyclical rebound but remains skeptical it will occur soon.
WLK is a high-risk, speculative buy only suitable for investors with a strong stomach for volatility and a long-term view. The stock is not a good buy for most investors at this moment due to its severe fundamental deterioration, including a -17.25% gross margin and -$544M quarterly net loss. However, for deep-value contrarians, the 0.85x PS ratio represents a historically cheap entry point if one believes the chemical cycle will recover in 2026-2027. The potential upside to analyst implied recovery is significant, but the downside to the 52-week low of $56.33 is a real -36% risk. It is a good buy only for those who can tolerate this risk and are betting on a cyclical turnaround.
WLK is strictly a long-term investment for patient capital. The company is in the depths of a cyclical downturn that may take several quarters or years to fully recover from, making it unsuitable for short-term trading. Its high volatility (evident from the recent 23.82% monthly drop) and lack of near-term positive catalysts argue against a short-term hold. The investment thesis is based on a multi-year cyclical recovery in the chemical and housing sectors. Given the need for fundamental repair and the stock's beta of 0.67 (implying lower long-term volatility than the market), investors should have a minimum holding period of 2-3 years to allow the cycle to play out.